RGC
Regencell Bioscience Holdings Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$5.79
−2.85%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-44.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 30, 2018 | BRANDOW PETER B · officer: EVP, General Counsel, Sec. | F-InKind | 1,283 | $23 |
| Jan 30, 2018 | MILES AMY E · director, officer: Chief Executive Officer | F-InKind | 4,511 | $23 |
| Jan 30, 2018 | Ownby David · officer: EVP, CFO and Treasurer | F-InKind | 1,440 | $23 |
| Jan 30, 2018 | DUNN GREGORY W · officer: President and COO | F-InKind | 1,738 | $23 |
| Jan 30, 2018 | DUNN GREGORY W · officer: President and COO | A-Award | 23,429 | $0.00 |
| Jan 30, 2018 | BRANDOW PETER B · officer: EVP, General Counsel, Sec. | A-Award | 17,298 | $0.00 |
| Jan 30, 2018 | MILES AMY E · director, officer: Chief Executive Officer | A-Award | 60,795 | $0.00 |
| Jan 30, 2018 | Ownby David · officer: EVP, CFO and Treasurer | A-Award | 19,416 | $0.00 |
| Jan 16, 2018 | DUNN GREGORY W · officer: President and COO | F-InKind | 2,118 | $23 |
| Jan 16, 2018 | Ownby David · officer: EVP, CFO and Treasurer | F-InKind | 1,454 | $23 |
| Jan 16, 2018 | DUNN GREGORY W · officer: President and COO | F-InKind | 1,755 | $23 |
| Jan 16, 2018 | Ownby David · officer: EVP, CFO and Treasurer | F-InKind | 1,756 | $23 |
| Jan 16, 2018 | BRANDOW PETER B · officer: EVP, General Counsel, Sec. | F-InKind | 1,564 | $23 |
| Jan 16, 2018 | BRANDOW PETER B · officer: EVP, General Counsel, Sec. | F-InKind | 1,297 | $23 |
| Jan 16, 2018 | MILES AMY E · director, officer: Chief Executive Officer | F-InKind | 5,498 | $23 |
| Jan 16, 2018 | MILES AMY E · director, officer: Chief Executive Officer | F-InKind | 4,549 | $23 |
| Jan 12, 2018 | Ownby David · officer: EVP, CFO and Treasurer | A-Award | 20,162 | $23 |
| Jan 12, 2018 | MILES AMY E · director, officer: Chief Executive Officer | A-Award | 81,116 | $23 |
| Jan 12, 2018 | BRANDOW PETER B · officer: EVP, General Counsel, Sec. | A-Award | 17,941 | $23 |
| Jan 12, 2018 | TYRRELL JACK · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | BELL THOMAS D JR · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | DUNN GREGORY W · officer: President and COO | A-Award | 23,341 | $23 |
| Jan 12, 2018 | CAMPBELL MICHAEL L · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | KEYTE DAVID H · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | Brymer Charles E · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | THOMAS LEE M · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | KAPLAN STEPHEN A · director | A-Award | 5,461 | $23 |
| Jan 12, 2018 | YEMENIDJIAN ALEX · director | A-Award | 5,461 | $23 |
| Jan 10, 2018 | BRANDOW PETER B · officer: EVP, General Counsel, Sec. | F-InKind | 6,030 | $23 |
| Jan 10, 2018 | Ownby David · officer: EVP, CFO and Treasurer | F-InKind | 1,345 | $23 |
Institutional positioning
13F filings over the trailing two quarters
New 32Increased 20Reduced 12Sold out 13
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 422,011 | Aug 12, 2026 |
| Alyeska Investment Group, L.P. | New Position | 416,261 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 415,569 | May 15, 2026 |
| JANE STREET GROUP, LLC | Increased | 176,348 | Aug 14, 2026 |
| Legal & General Group Plc | Increased | 128,000 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 108,500 | Sep 2, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 72,700 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 70,829 | Aug 14, 2026 |
| MAREX GROUP PLC | New Position | 63,200 | May 13, 2026 |
| XTX Topco Ltd | New Position | 60,061 | Aug 14, 2026 |
| Amundi | Increased | 47,159 | Aug 11, 2026 |
| UBS Group AG | Increased | 43,208 | Aug 13, 2026 |
| Quadrature Capital Ltd | New Position | 41,750 | Aug 7, 2026 |
| CITADEL ADVISORS LLC | Increased | 34,300 | May 15, 2026 |
| GSA CAPITAL PARTNERS LLP | New Position | 31,569 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 30, 2018